Safety Assessment of SAR341402 and NovoLog ® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
Condition: Type 1 Diabetes Mellitus Interventions: Drug: Insulin aspart SAR341402; Drug: Insulin aspart Sponsor: Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials